Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2022-12-21 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (391 characters) and consists solely of a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no mention of any report type, financial data, or corporate event. Given the lack of content and the nature of the text, it does not fit any specific filing category and is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories.
2022-12-21 English
Please refer to our earlier communication dated 9th November 2022, with reference to the proposed acquisition of animal healthcare business from Agilis Healthcare Private Limited. Now ....
Regulatory Filings Classification · 95% confidence The document text is extremely short (391 characters) and consists solely of a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no indication of any report, announcement, or regulatory filing content. Given the lack of any report or announcement content, and the presence of only a signature, this document best fits the fallback category for miscellaneous filings that do not fit other categories, which is Regulatory Filings (RNS).
2022-12-21 English
General updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about a regulatory update concerning the company's ability to access the capital market. It references a SEBI order and its reduction by the SEBI Appellate Tribunal, indicating a compliance and regulatory disclosure. The document is short (2885 characters) and serves as an official announcement of a regulatory event rather than a financial report or detailed filing. It does not contain financial data, audit information, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2022-11-29 English
The SEBI Appellate Tribunal, Mumbai Bench; wide its order dated 23rd November 2022, (received by the Company on 29th November 2022) has reduced the debarment period of the Company, from ....
Regulatory Filings Classification · 90% confidence The document text is extremely short (410 characters) and consists solely of a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no indication of any report, announcement, or regulatory filing content. Given the lack of any report or announcement content, and the presence of a digital signature only, this document best fits the fallback category of Regulatory Filings (RNS).
2022-11-29 English
Loss of share certificate
Regulatory Filings Classification · 100% confidence The document text is extremely short (72 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of any meaningful information, the document cannot be classified as a report or announcement. It fits best as a Regulatory Filing (RNS) fallback category due to absence of specific content.
2022-11-24 English
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; we wish to inform you that the Company has issued duplicates share certificates
Regulatory Filings
2022-11-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.